Friday, November 18, 2005

In the US 40,000 People Died from Metastatic Breast Cancer in 2003, with Median Survival Rates Estimated to Be Two Years

Genetic Engineering News, November 18, 2005
In 2003, approximately 40,000 deaths in the United States were attributed to breast cancer. While significant therapeutic advances for early-stage disease have emerged in recent years, an estimated 30% to 40% of all patients (in Western countries) ultimately develop metastatic breast cancer (MBC). Median survival for MBC patients is estimated at an all too brief two years, underscoring tremendous unmet need among the MBC population.
Profiles in Metastatic Breast Cancer spotlights for drug developers potential opportunities for clinical and commercial advances in MBC drug development. These potential opportunities are identified ...


Post a Comment

<< Home

/* WebRing Code */